When Responding To A Warning Letter, Act Within 15 Days
Executive Summary
When an FDA inspection of a drug manufacturing plant turns up potential violations that are noted on the official Form 483 report, the company should respond in complete detail within 15 days or risk having its response officially disregarded.
You may also be interested in...
Internal Quality Unit Helps UK’s Klinge Chemicals Resolve FDA Warning Letter
The company did not find it necessary to hire outside consultants to resolve water quality problems FDA cited in a 2010 warning letter.
Sanofi Still Needs Fix For Adverse Event Reporting As FDA Seeks Retrospective Study, Pinches Accenture
FDA's warning letter to Sanofi-Aventis US over the firm's failure to resolve problems that have delayed adverse event reporting shows the agency is emphasizing the issue in its compliance efforts – and becoming more pointed in its requests for fixes.
Sanofi Still Needs Fix For Adverse Event Reporting As FDA Seeks Retrospective Study, Pinches Accenture
FDA's warning letter to Sanofi-Aventis US over the firm's failure to resolve problems that have delayed adverse event reporting shows the agency is emphasizing the issue in its compliance efforts – and becoming more pointed in its requests for fixes.